7 August 2025

Clinical research Rheumatoid Arthritis

Placebo response higher in RA trials from lower-income countries

7 August 2025

Musculoskeletal Pain

Cognitive therapy rewires back pain for the long haul

7 August 2025

Cannabis Rheumatoid Arthritis

Small Aussie pharma in topical CBD trial for RA

24 July 2025

Biologics Rheumatology

Secukinumab falls short in GCA trial

24 July 2025

Arthritis Gout TGA

TGA warning on supplement laced with prescription drugs

24 July 2025

Clinical research Psoriatic Athritis

Zasocitinib shows promise in psoriatic arthritis phase 2b trial

24 July 2025

AI AIDH General Practice Technology

AIDH releases new guidance on AI scribes

10 July 2025

Biologics Cancer Rheumatoid Arthritis

ORAL Surveillance cancer signal replicated in observational data

10 July 2025

AI EULAR Technology

AI a hot topic at EULAR 2025

10 July 2025

ACR EULAR Lupus

EULAR unveils new recommendations for lupus nephritis

26 June 2025

Digital Health Technology

NHS drops ‘medical device’ bomb on AI scribes in UK

26 June 2025

ACR EULAR Guidelines osteomyelitis Paediatrics

‘Crucial foundation’: new criteria for paediatric bone disease

26 June 2025

EULAR Gout

Advances in gout management presented at EULAR 2025

12 June 2025

Imaging pathology

What impact does corporate control have on imaging clinics?

12 June 2025

EULAR Psoriatic Athritis

Early biologic intervention yields lasting benefit in PsA

12 June 2025

cardiovascular Clinical research Pharmaceuticals Rheumatoid Arthritis

Upadacitinib outperforms adalimumab regardless of CV risk